期刊
BIOCHEMISTRY AND CELL BIOLOGY
卷 -, 期 -, 页码 -出版社
CANADIAN SCIENCE PUBLISHING
DOI: 10.1139/bcb-2023-0207
关键词
-
BioCanRx held its first post-pandemic in-person Summit for Cancer Immunotherapy in Montreal, Canada in November 2022. The event brought together various stakeholders to discuss the current and future state of biotherapeutics for cancer in Canada and beyond. The meeting involved plenaries, keynote speakers, debates, and panel discussions, and also emphasized the importance of including the patient perspective through initiatives like the Learning Institute.
From 19 to 21 November 2022, BioCanRx held its first post-pandemic in-person Summit for Cancer Immunotherapy in Montreal, Canada. The meeting was well attended by patients, trainees, researchers, clinicians, and industry professionals, who came together to discuss the current state and future of biotherapeutics for cancer in Canada and beyond. Three plenaries, three keynote speakers, a lively debate, and panel discussions, together with poster sessions and a social event, made the event memorable and productive. The current state of cellular therapies, cellular engineering, clinical trials, and the role of the cancer microbiome were discussed in plenary session, and the patient voice was welcomed and present throughout the meeting, in large part due to the Learning Institute, a BioCanRx initiative to include patient partners in research. In this meeting review, we highlight the platform presentations, keynote speakers, debate combatants, panellists, and the patient perspective on the annual meeting.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据